Omisertinib is a type of cancer medicine that belongs to the class of protein kinase inhibitors. Specifically, it is a powerful tyrosine kinase inhibitor that is taken orally. It selectively inhibits epidermal growth factor receptors with mutations. It has high potency against non-small cell lung cancers.
This drug inhibits the development and spread of malignant cells in the body.